Reggiani, Angelo

Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1

Conquet, F., Bashir, Z. I., Davies, C. H., Daniel, H., Ferraguti, F., Bordi, F., Franz-Bacon, K., Reggiani, A., Matarese, V., Condé, F., et al. (1994) · Nature

Neuroscience and Neuropharmacology ResearchGenetics and Neurodevelopmental Disorders

Cited by 743

CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms

Beltramo, M., Bernardini, N., Bertorelli, R., Campanella, M., Nicolussi, E., Fredduzzi, S., & Reggiani, A. (2006) · European Journal of Neuroscience

Pain Mechanisms and TreatmentsCannabis and Cannabinoid Research

Cited by 290

A catalytically silent FAAH-1 variant drives anandamide transport in neurons

Fu, J., Bottegoni, G., Sasso, O., Bertorelli, R., Rocchia, W., Masetti, M., Guijarro, A., Lodola, A., Armirotti, A., Garau, G., et al. (2012) · Nature Neuroscience

Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments

Cited by 175

Combining Galantamine and Memantine in Multitargeted, New Chemical Entities Potentially Useful in Alzheimer’s Disease

Simoni, E., Daniele, S., Bottegoni, G., Pizzirani, D., Trincavelli, M. L., Goldoni, L., Tarozzo, G., Reggiani, A., Martini, C., Piomelli, D., et al. (2012) · Journal of Medicinal Chemistry

Cholinesterase and Neurodegenerative DiseasesChemical synthesis and alkaloids

Cited by 163

Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions

Sasso, O., Bertorelli, R., Bandiera, T., Scarpelli, R., Colombano, G., Armirotti, A., Moreno-Sanz, G., Reggiani, A., & Piomelli, D. (2012) · Pharmacological Research

Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments

Cited by 96

Galantamine potentiates the neuroprotective effect of memantine against NMDA‐induced excitotoxicity

Lopes, J. P., Tarozzo, G., Reggiani, A., Piomelli, D., & Cavalli, A. (2013) · Brain and Behavior

Neuroscience and Neuropharmacology ResearchNicotinic Acetylcholine Receptors Study

Cited by 64

Novel fragile X syndrome 2D and 3D brain models based on human isogenic FMRP-KO iPSCs.

Brighi, C., Salaris, F., Soloperto, A., Cordella, F., Ghirga, S., de Turris, V., Rosito, M., Porceddu, P. F., D’Antoni, C., Reggiani, A., et al. (2021) · Cell Death & Disease

Genetics and Neurodevelopmental DisordersPluripotent Stem Cells Research

Cited by 56